History of heparin

Area of Science:

• Pharmacology and Biochemistry
• Medical History

Background:

• Heparin, discovered in 1916, is a critical anticoagulant.
• Its commercial production and clinical trials began in the 1930s.
• Understanding heparin's complex structure and mechanism of action has evolved significantly.

Observation:

• Early research faced challenges in elucidating heparin's precise chemical structure.
• Key breakthroughs included establishing the basic disaccharide unit by the 1960s.
• Identification of a specific pentasaccharide sequence crucial for antithrombin binding occurred in the 1970s.

Findings:

• A unique pentasaccharide sequence essential for antithrombin binding and anticoagulant activity was identified.
• This crucial pentasaccharide sequence was successfully synthesized in 1983.
• Research advanced the understanding of heparin chain heterogeneity and fine structure.

Implications:

• The discovery of the antithrombin-binding pentasaccharide revolutionized anticoagulant therapy.
• Development of low-dose heparin and low-molecular-weight heparin (LMWH) improved patient outcomes.
• These advancements expanded the clinical applications of heparin in preventing thrombosis.